The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer
Open accessAbstract
Cancers are highly heterogeneous and contain many passenger and driver mutations. To functionally identify tumor suppressor genes relevant to human cancer, we compiled pools of short harpin RNAs (shRNAs) targeting the mouse orthologs of genes recurrently deleted in a series of human hepatocellular carcinomas, and tested their ability to promote tumorigenesis in a mosaic mouse model. In contrast to randomly selected shRNA pools, many deletion-specific pools accelerated hepatocarcinogenesis in mice. Through further analysis, we identified and validated 13 tumor suppressor genes, 12 of which had not been linked to cancer before. One gene, XPO4, encodes a nuclear export protein whose substrate EIF5A2 is amplified in human tumors, is required for proliferation of XPO4-deficient tumor cells, and promotes hepatocellular carcinoma in mice. Our results establish the feasibility of in vivo RNAi screens and illustrate how combining cancer genomics, RNA interference, and mosaic mouse models can facilitate the functional annotation of the cancer genome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationMassagué, J. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043051 · Cited by 1,899
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Self-citationHepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Second-generation shRNA libraries covering the mouse and human genomes
Silva, J. M., Li, M. Z., Chang, K., Ge, W., Golding, M. C., Rickles, R. J., Siolas, D., Hu, G., Paddison, P. J., Schlabach, M. R., et al. (2005) · Nature Genetics · doi:10.1038/ng1650 · Cited by 622
Self-citationColorectal cancer and genetic alterations in the Wnt pathway
Segditsas, S., & Tomlinson, I. (2006) · Oncogene · doi:10.1038/sj.onc.1210059 · Cited by 591
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R. A., Hemann, M. T., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G. J., & Lowe, S. W. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 524
Self-citationDissecting p53 tumor suppressor functions in vivo
Schmitt, C. A., Fridman, J. S., Yang, M., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00047-8 · Cited by 485
Self-citationNuclear transport and cancer: from mechanism to intervention
Kau, T. R., Way, J. C., & Silver, P. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1274 · Cited by 468
Lucito, R., Healy, J., Alexander, J., Reiner, A., Esposito, D., Chi, M., Rodgers, L., Brady, A., Sebat, J., Troge, J., et al. (2003) · Genome Research · doi:10.1101/gr.1349003 · Cited by 441
Self-citationThe mechanism of action of protein synthesis initiation factors from rabbit reticulocytes.
Benne, R., & Hershey, J. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40805-2 · Cited by 433
Cancer Modeling in the Modern Era
Van Dyke, T., & Jacks, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00621-9 · Cited by 358
Hemann, M. T., Fridman, J. S., Zilfou, J. T., Hernando, E., Paddison, P. J., Cordon-Cardo, C., Hannon, G. J., & Lowe, S. W. (2003) · Nature Genetics · doi:10.1038/ng1091 · Cited by 354
Self-citationAmplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer
Guan, Y., Kuo, W.-L., Stilwell, J. L., Takano, H., Lapuk, A. V., Fridlyand, J., Mao, J.-H., Yu, M., Miller, M. A., Santos, J. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2882 · Cited by 347
Novel patterns of genome rearrangement and their association with survival in breast cancer
Hicks, J., Krasnitz, A., Lakshmi, B., Navin, N. E., Riggs, M., Leibu, E., Esposito, D., Alexander, J., Troge, J., Grubor, V., et al. (2006) · Genome Research · doi:10.1101/gr.5460106 · Cited by 319
Self-citationTranslating insights from the cancer genome into clinical practice
Chin, L., & Gray, J. W. (2008) · Nature · doi:10.1038/nature06914 · Cited by 300
PTEN function in normal and neoplastic growth
Chow, L. M. L., & Baker, S. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.042 · Cited by 275
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Krimpenfort, P., IJpenberg, A., Song, J.-Y., van der Valk, M., Nawijn, M., Zevenhoven, J., & Berns, A. (2007) · Nature · doi:10.1038/nature06084 · Cited by 269
The links between axin and carcinogenesis
Salahshor, S., & Woodgett, J. R. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.009506 · Cited by 249
Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer
Kendall, J., Liu, Q., Bakleh, A., Krasnitz, A., Nguyen, K. C. Q., Lakshmi, B., Gerald, W. L., Powers, S., & Mu, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708286104 · Cited by 236
Self-citationDeregulation of the Akt Pathway in Human Cancer
Tokunaga, E., Oki, E., Egashira, A., Sadanaga, N., Morita, M., Kakeji, Y., & Maehara, Y. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908783497140 · Cited by 220
Exportin 4: a mediator of a novel nuclear export pathway in higher eukaryotes
Lipowsky, G. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4362 · Cited by 217
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma
Xue, W., Krasnitz, A., Lucito, R., Sordella, R., VanAelst, L., Cordon-Cardo, C., Singer, S., Kuehnel, F., Wigler, M., Powers, S., et al. (2008) · Genes & Development · doi:10.1101/gad.1672608 · Cited by 187
Self-citationPark, M. H., Wolff, E. C., Lee, Y. B., et al. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46861-5 · Cited by 151
Oncogenic Role of eIF-5A2 in the Development of Ovarian Cancer
Guan, X., Fung, J. M.-W., Ma, N., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3747 · Cited by 141
Genetics of hepatocellular carcinoma
Teufel, A., Staib, F., Kanzler, S., Weinmann, A., Schulze-Bergkamen, H., & Galle, P.-R. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i16.2271 · Cited by 126
Replication stress induces tumor-like microdeletions in FHIT /FRA3B
Durkin, S. G., Ragland, R. L., Arlt, M. F., Mullé, J. G., Warren, S. T., & Glover, T. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708097105 · Cited by 126
Comparative and integrative functional genomics of HCC
Lee, J.-S., & Thorgeirsson, S. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209561 · Cited by 121
Yabuta, N., Fujii, T., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Nishiguchi, H., Endo, Y., Toji, S., Tanaka, H., Nishimune, Y., et al. (2000) · Genomics · doi:10.1006/geno.1999.6065 · Cited by 112
The Mechanism of Nuclear Export of Smad3 Involves Exportin 4 and Ran
Kurisaki, A., Kurisaki, K., Kowanetz, M., Sugino, H., Yoneda, Y., Heldin, C., & Moustakas, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1318-1332.2006 · Cited by 104
TGF-β inhibitors for the treatment of cancer
Lahn, M. M. F., Kloeker, S., & Berry, B. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.629 · Cited by 84
Zender, L., Xue, W., Cordon‐Cardo, C., Hannon, G. J., Lucito, R., Powers, S., Flemming, P., Spector, M. S., & Lowe, S. W. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.059 · Cited by 69
Self-citationLindern, M. V., Fornerod, M. W. J., Soekarman, N., van Baal, S., Jaegle, M., Hagemeijer, A., Bootsma, D., & Grosveld, G. C. (1992) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(11)80049-1 · Cited by 65
The Transcriptional Repressor Glis2 Is a Novel Binding Partner for p120 Catenin
Hosking, C. R., Ulloa, F., Hogan, C., Ferber, E. C., Figueroa, A., Gevaert, K., Birchmeier, W., Briscoe, J., & Fujita, Y. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-10-0941 · Cited by 62
Defining the blueprint of the cancer genome
Velculescu, V. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn096 · Cited by 59
Cited by
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
High-throughput functional genomics using CRISPR-Cas9
Shalem, O., Sanjana, N. E., & Zhang, F. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3899 · Cited by 1,233
Lujambio, A., & Lowe, S. W. (2012) · Nature · doi:10.1038/nature10888 · Cited by 1,084
Self-citationBarash, Y., Calarco, J. A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B. J., & Frey, B. J. (2010) · Nature · doi:10.1038/nature09000 · Cited by 895
Metadata
- Authors
- Zender, L., Xue, W., Zuber, J., Semighini, C. P., Krasnitz, A., Ma, B., Zender, P., Kubicka, S., Luk, J. M., Schirmacher, P., Richard McCombie, W., Wigler, M., Hicks, J., Hannon, G. J., Powers, S., & Lowe, S. W.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 135
- Issue
- 5
- Pages
- 852-864
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2167005345
- Cited by
- 428
- References
- 37
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.